APOB and coronary artery disorder: Lemieux et al. [8] first verified that the HTGW phenotype could be used as an inexpensive screening tool to identify men characterized by the atherogenic metabolic triad (hyperinsulinemia, elevated apolipoprotein B, and small dense low-density lipoprotein-cholesterol particles) and at increased risk of coronary artery disease (CAD).